Brain-Cleaning Beds, Forever Chemicals, Peptide Freedom, Coffee for Your Heart, and More : 1568

Scientists Test Vibrating Mattress To Help Clear Alzheimer's-Related Proteins From The Brain 

Researchers at the University of Oulu in Finland tested a vibrating mattress combined with nitroglycerin, a blood-vessel-relaxing drug, in 29 healthy adults and found that blood levels of amyloid-beta 42 increased approximately 35% following the combined treatment. Published in Nature Communications, the study also identified MRI changes suggesting altered cerebrospinal fluid dynamics, potentially involving the glymphatic system and mechanosensitive Piezo1 ion channels. While the results suggest increased movement of brain-associated proteins into circulation, they do not establish that Alzheimer's plaques were removed or that cognition improved. Host Dave Asprey explores the potential of mechanical stimulation, nitric oxide signaling, and brain waste clearance as emerging approaches to neurodegenerative disease prevention, and why sleep and vascular health remain essential to protecting long-term cognitive performance. 

Sources: 

https://doi.org/10.1038/s41467-026-78894-y 

~~~

Yale Researchers Discover Taurine Controls A Key Inflammatory Switch Linked To Aging 

Yale researchers identified a previously unrecognized role for taurine in regulating the NLRP3 inflammasome, an immune signaling complex associated with chronic inflammation and biological aging. Published in Cell, the research found that activated macrophages released up to 80% of their intracellular taurine, while restoring taurine suppressed inflammatory signaling. Surprisingly, circulating taurine levels were higher in older adults than younger adults, challenging the assumption that taurine universally declines with age and highlighting the importance of intracellular nutrient regulation. Host Dave Asprey examines the connection between taurine, inflammaging, immune function, and longevity, explaining why cellular nutrient availability may matter more than blood concentrations and what this emerging mechanism means for supplementation and inflammation management. 

Sources: 

https://doi.org/10.1016/j.cell.2026.09.061 

~~~

Blood And Plasma Donation Shown To Reduce Forever Chemicals In Human Trial 

A randomized clinical trial involving 285 Australian firefighters found that regular blood and plasma donation significantly reduced circulating concentrations of certain PFAS, the persistent environmental pollutants commonly known as forever chemicals. Published in JAMA Network Open, the study found that plasma donation every six weeks reduced average PFOS concentrations by 2.9 ng/mL over 12 months, compared with a 1.1 ng/mL reduction from whole-blood donation every 12 weeks and virtually no change in the control group. Because PFAS bind to proteins in blood, removing plasma offers a direct method of reducing circulating chemical concentrations, although the trial did not establish long-term health benefits. Host Dave Asprey explains why this physical removal strategy deserves attention alongside conventional detoxification approaches, and how reducing exposure through drinking water, food packaging, and environmental sources remains a critical first step. 

Sources: 

https://doi.org/10.1001/jamanetworkopen.2022.6257 

~~~

HHS Eases Restrictions On Six Popular Biohacking Peptides Including BPC-157 And MOTS-c 

On October 28, 2026, the Department of Health and Human Services announced a draft enforcement-discretion policy covering six compounded peptides: BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500. Under the interim approach, HHS says it does not intend to take enforcement action against qualifying compounders when specific manufacturing, sourcing, formulation, labeling, and adverse-event reporting conditions are satisfied, while the FDA's formal regulatory evaluation continues. The announcement represents a significant shift for compounds being investigated or promoted for tissue repair, inflammation, mitochondrial function, cognitive performance, and longevity, although none received FDA approval through this action. Host Dave Asprey discusses what the policy could mean for peptide access, pharmaceutical regulation, product purity, and medical oversight, and why better manufacturing standards must accompany expanded access to experimental therapies. 

Sources: 

https://www.federalregister.gov/d/2026-22192 

https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf 

https://www.foley.com/insights/publications/2026/10/peptides-hhs-announces-limited-enforcement-discretion-for-compounding-of-six-peptides/ 

~~~

Drinking Coffee Linked To 39% Lower Recurrence Hazard Of Atrial Fibrillation In Clinical Trial 

A randomized clinical trial published in JAMA found that patients assigned to drink at least one cup of caffeinated coffee daily experienced fewer recurring episodes of atrial fibrillation or atrial flutter following electrical cardioversion than patients assigned to avoid caffeinated beverages. The six-month DECAF trial followed 200 adults and found arrhythmia recurrence in 47% of coffee drinkers compared with 64% of participants assigned to abstinence, corresponding to a 39% lower recurrence hazard in the time-to-event analysis. The findings challenge routine recommendations to avoid coffee among patients with existing atrial fibrillation, although the trial did not establish whether caffeine, coffee polyphenols, or associated behaviors produced the benefit. Host Dave Asprey explores caffeine's effects on cardiovascular function, adenosine signaling, and inflammation, explaining why individualized responses matter more than blanket dietary restrictions. 

Sources: 

https://doi.org/10.1001/jama.2025.21056 

This episode is designed for biohackers, longevity enthusiasts, and high-performance listeners interested in Alzheimer's prevention, brain detoxification, immune aging, environmental toxins, peptide therapies, and cardiovascular optimization. Host Dave Asprey examines emerging research on glymphatic clearance, taurine and the NLRP3 inflammasome, PFAS removal through plasma donation, changing federal peptide regulations, and coffee's surprising relationship with atrial fibrillation, translating complex science into practical considerations for protecting cognitive function, reducing inflammation, and improving long-term health. 

New episodes every Tuesday, Thursday, Friday, and Sunday. 

Keywords: vibrating mattress brain detox, glymphatic system Alzheimer's, amyloid beta clearance, nitric oxide brain health, Piezo1 mechanosensitive channels, taurine inflammaging, NLRP3 inflammasome, taurine immune cells, Yale taurine study, chronic inflammation aging, PFAS forever chemicals, plasma donation PFAS removal, blood donation detox, PFOS reduction, BPC-157 peptide regulations, HHS peptide policy 2026, MOTS-c, Epitalon, KPV peptide, Semax, TB-500, FDA peptide compounding, coffee atrial fibrillation, DECAF clinical trial, caffeine heart health, cardiovascular longevity, Dave Asprey, The Human Upgrade, biohacking news 2026 

Thank you to our sponsors!   

Resources:   

• Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/ 

• Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ 

• Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today.  

• Danger Coffee: https://dangercoffee.com/discount/dave15   

• My Daily Supplements: SuppGrade Labs (15% Off)   

• Favorite Blue Light Blocking Glasses: TrueDark (15% Off)   

• Dave Asprey’s BEYOND Conference: https://beyondconference.com   

• Dave Asprey’s New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated  

• Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ 

• Upgrade Labs: https://upgradelabs.com   

Timestamps: 

00:00 - Intro 

00:18 - Vibrating Mattress & Brain Clearance 

01:54 - Taurine & Inflammation 

03:17 - PFAS & Plasma Donation 

05:26 - HHS Peptide Policy 

07:32 - Coffee & Atrial Fibrillation 

09:10 - Outro 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.